GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition

UK pharmaceuticals giant GSK PLC said Tuesday that it plans to buy Aiolos Bio Inc. for $1.4 billion as it seeks to expand its respiratory pipeline.

The post is from Mad Mad News